Sales Growth YoY (Last 12 Months): MiNK Therapeutics, Inc. (INKT)

Public company logo of MiNK Therapeutics, Inc (INKT)

MiNK Therapeutics, Inc. (INKT) revenue growth year-over-year for the TTM reflects the impact of a strong team of immunologists and an options system. However, international disputes are hindering testing and material supplies, while strict FDA oversight and production costs create significant barriers. The current level of 0.00 shows the value of this parameter, linking the asset's market value to its actual sales dynamics.

MiNK Therapeutics (INKT) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/19/2026

MiNK Therapeutics (INKT) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:MiNK Therapeutics, Inc.
Product sample of minktherapeutics.com

MiNK Therapeutics, Inc. (INKT) focuses on developing cell-based therapies for oncological diseases while maintaining a minimal environmental footprint through bio-waste disposal. This biotech's revenue dynamics are digitized by comparing current twelve-month periods. This metric measures the expansion rate of the sales market by neutralizing short-term anomalies. It is critical for investors to distinguish sustainable growth from stagnating demand. By analyzing the annual growth in sales volume via TTM, one can assess the viability of the business model.

Competitors of MiNK Therapeutics, Inc. (INKT)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)